Search Tag: Company’s Growth
2022 17 Oct
Dunn brings expertise in developing data and analytical products for commercialization to leading biopharmaceutical, informatics, diagnostic and precision oncology companies. M2GEN, a bioinformatics company accelerating discoveries in oncology research through industry-leading data and analytics, today announced the appointment of K yle Dunn...Read more